Submission Details
| 510(k) Number | K041951 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 20, 2004 |
| Decision Date | November 15, 2004 |
| Days to Decision | 118 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
K041951 is an FDA 510(k) clearance for the XPECT CLOSTRIDIUM DIFFICILE TOXIN A/B, a Reagents, Clostridium Difficile Toxin (Class I — General Controls, product code LLH), submitted by Remel, Inc. (Lenexa, US). The FDA issued a Cleared decision on November 15, 2004, 118 days after receiving the submission on July 20, 2004. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.2660.
| 510(k) Number | K041951 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 20, 2004 |
| Decision Date | November 15, 2004 |
| Days to Decision | 118 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
| Product Code | LLH — Reagents, Clostridium Difficile Toxin |
| Device Class | Class I — General Controls |
| CFR Regulation | 21 CFR 866.2660 |